Structural Formulae (Pol0c 0000 01)
Polymyxin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-321
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 63323-321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Fresenius Kabi Logo (Pol0c 0000 02)
Principal Display Panel – Vial Label (Pol0c 0000 03)
This is a description of an injectable medicine called Polymyxin B, which comes in a vial containing 500,000 units per dose. It is a prescription-only drug and should be administered by a healthcare professional via intramuscular, intravenous, and/or intrathecal routes in hospitalized patients only due to its neuro- and nephrotoxic effects. It is important to store the drug under specific temperature conditions before and after reconstitution, and any unused portion must be discarded after 72 hours. Dosages should not exceed 25,000 units per kg per day. The medicine comes from the manufacturer Fresenius Kabi and should only be used in hospital settings.*
Principal Display Panel – Vial Tray (Pol0c 0000 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
